Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (201-210 of 792) with videos related to

Pageof 80
Sort By:
Journal of the American Heart Association|June 11, 2020
Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and OutcomesJin Joo Park, Alexandre Mebazaa, In-Chang Hwang, et al.
British Journal of Anaesthesia|December 13, 2021
Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approachRomain Barthélémy, Manuel Kindermans, Paul Delval, et al.
European Journal of Heart Failure|March 4, 2008
Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: results from a short and mid-term studyPaul Milliez, Olivier Thomas, Abdeddayem Haggui, et al.
The Biochemical Journal|July 5, 2002
Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activitySophie Lanone, Philippe Manivet, Jacques Callebert, et al.
International Journal of Cardiology|February 7, 2018
Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trialsNicolas Vodovar, Alexandre Mebazaa, James L Januzzi, et al.
European Journal of Heart Failure|July 14, 2007
Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failureChris Adamopoulos, Faiez Zannad, Renaud Fay, et al.
Intensive Care Medicine|November 19, 2010
Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methodsAlexandre Mebazaa, John Parissis, Raphael Porcher, et al.
Critical Care (London, England)|September 1, 2006
Endotoxin-induced myocardial dysfunction in senescent ratsSandrine Rozenberg, Sophie Besse, Hélène Brisson, et al.
British Journal of Clinical Pharmacology|June 2, 2018
Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjectsChristopher Geven, Dirk van Lier, Alice Blet, et al.
Annals of Laboratory Medicine|September 26, 2023
Predictive Performance of Neutrophil Gelatinase Associated Lipocalin, Liver Type Fatty Acid Binding Protein, and Cystatin C for Acute Kidney Injury and Mortality in Severely Ill PatientsAyu Asakage, Shiro Ishihara, Louis Boutin, et al.
Pageof 80

Showing results (201-210 of 792) with videos related to

Sort By:
Pageof 80
Journal of the American Heart Association|June 11, 2020
Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and OutcomesJin Joo Park, Alexandre Mebazaa, In-Chang Hwang, et al.
British Journal of Anaesthesia|December 13, 2021
Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approachRomain Barthélémy, Manuel Kindermans, Paul Delval, et al.
European Journal of Heart Failure|March 4, 2008
Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: results from a short and mid-term studyPaul Milliez, Olivier Thomas, Abdeddayem Haggui, et al.
The Biochemical Journal|July 5, 2002
Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activitySophie Lanone, Philippe Manivet, Jacques Callebert, et al.
International Journal of Cardiology|February 7, 2018
Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trialsNicolas Vodovar, Alexandre Mebazaa, James L Januzzi, et al.
European Journal of Heart Failure|July 14, 2007
Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failureChris Adamopoulos, Faiez Zannad, Renaud Fay, et al.
Intensive Care Medicine|November 19, 2010
Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methodsAlexandre Mebazaa, John Parissis, Raphael Porcher, et al.
Critical Care (London, England)|September 1, 2006
Endotoxin-induced myocardial dysfunction in senescent ratsSandrine Rozenberg, Sophie Besse, Hélène Brisson, et al.
British Journal of Clinical Pharmacology|June 2, 2018
Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjectsChristopher Geven, Dirk van Lier, Alice Blet, et al.
Annals of Laboratory Medicine|September 26, 2023
Predictive Performance of Neutrophil Gelatinase Associated Lipocalin, Liver Type Fatty Acid Binding Protein, and Cystatin C for Acute Kidney Injury and Mortality in Severely Ill PatientsAyu Asakage, Shiro Ishihara, Louis Boutin, et al.
Pageof 80